BioCentury
ARTICLE | Company News

CeNeS, Ares-Serono deal

April 3, 2000 7:00 AM UTC

CeNeS will use its prolonged release gels and injection drug delivery technology to generate a new formulation of an Ares-Serono fertility drug. CeNeS will receive research fees and has manufacturing ...